E-LIB Suche - Ergebnisse für: Shoumariyeh, Khalid

1

MPN-334 Safety and Efficacy of Bezuclastinib (CGT9486), a N..:

Vachhani, Pankit ; Tashi, Tsewang ; Schiller, Gary...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S429-S430 , 2024

Link: https://doi.org/10.1016/..

2

Prevalence of hypersensitivity reactions in various forms o..:

Niedoszytko, Marek ; Gorska, Aleksandra ; Brockow, Knut...
Allergy. 79 (2024) 9 - p. 2470-2481 , 2024

Link: https://doi.org/10.1111/..

3

Allogeneic Hematopoietic Cell Transplantation in Advanced S..:

Lübke, Johannes ; Christen, Deborah ; Schwaab, Juliana...
Leukemia. 38 (2024) 4 - p. 810-821 , 2024

Link: https://doi.org/10.1038/..

4

Serum chemistry profiling and prognostication in systemic m..:

Lübke, Johannes ; Schmid, Alicia ; Christen, Deborah...
Blood Advances. 8 (2024) 11 - p. 2890-2900 , 2024

Link: https://doi.org/10.1182/..

5

Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Hi..:

Vachhani, Pankit ; Tashi, Tsewang ; Schiller, Gary...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) - p. S204 , 2024

Link: https://doi.org/10.1016/..

6

ROCK1/2 signaling contributes to corticosteroid-refractory ..:

Maas-Bauer, Kristina ; Stell, Anna-Verena ; Yan, Kai-Li...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

7

Mast cell leukemia: clinical and molecular features and sur..:

Kennedy, Vanessa E. ; Perkins, Cecelia ; Reiter, Andreas...
Blood Advances. 7 (2023) 9 - p. 1713-1724 , 2023

Link: https://doi.org/10.1182/..

8

Elevated RIPK3 correlates with disease burden in myelofibro..:

Dill, Veronika ; Wagner, Celina V. ; Keller, Eva C....
Blood Advances. 7 (2023) 7 - p. 1219-1224 , 2023

Link: https://doi.org/10.1182/..

9

Phase II trial of hypomethylating agent combined with nivol..:

Apostolova, Petya ; Kreutmair, Stefanie ; Toffalori, Cristina...
British Journal of Haematology. 203 (2023) 2 - p. 264-281 , 2023

Link: https://doi.org/10.1111/..

10

GPRC5C drives branched-chain amino acid metabolism in leuke..:

Zhang, Yu Wei ; Velasco-Hernandez, Talia ; Mess, Julian...
Blood Advances. 7 (2023) 24 - p. 7525-7538 , 2023

Link: https://doi.org/10.1182/..

11

Mast cell deficiency prevents BCR::ABL1 induced splenomegal..:

Langhammer, Melanie ; Schöpf, Julia ; Jaquet, Timo...
Leukemia. 37 (2023) 7 - p. 1474-1484 , 2023

Link: https://doi.org/10.1038/..

12

Patient‐derived xenograft mouse models to investigate tropi..:

Isbell, Lisa Kristina ; Tschuch, Cordula ; Doostkam, Soroush...
Neuropathology and Applied Neurobiology. 49 (2023) 2 - p. , 2023

Link: https://doi.org/10.1111/..

13

Potent high-avidity neutralizing antibodies and T cell resp..:

Keppler-Hafkemeyer, Andrea ; Greil, Christine ; Wratil, Paul R....
Nature Cancer. , 2022

Link: https://doi.org/10.1038/..

14

Treatment of therapy-related acute myeloid leukemia and und..:

Shoumariyeh, Khalid ; Jung, Johannes ; Rassner, Michael...
Annals of Hematology. 100 (2021) 6 - p. 1637-1640 , 2021

Link: https://doi.org/10.1007/..

15

Comprehensive characterization of central BCL-2 family memb..:

Odinius, Timo O. ; Buschhorn, Lars ; Wagner, Celina...
Journal of Cancer Research and Clinical Oncology. 148 (2021) 2 - p. 331-340 , 2021

Link: https://doi.org/10.1007/..